• People ignorant of cancers caused by smoking

    Updated: 2012-06-30 00:01:00
    Cancer Research UK today reveals the shocking level of ignorance about smoking and cancer among the UK public in a comprehensive new survey of more than 4000 people.

  • Important Survey for you

    Updated: 2012-06-29 17:14:49
    Here’s a great opportunity to participate in an advanced prostate cancer marketing survey, earn $40 dollars for yourself and help move our understanding of our disease just a little bit further forward. *What is the purpose?* Understanding patients’ knowledge and perceptions of treatments for prostate cancer, so researchers can understand how prostate cancer affects patients [...]

  • Failing Zytiga – Some Requirements to Access the MDV-3100 Early Access Trial

    Updated: 2012-06-29 16:17:09
    Many of us in the United States with advanced prostate cancer who have failed Zytiga are looking to enter the Early Access MDV-3100 Clinical Trial. However, you need to be aware that there are some requirements you will need to meet prior to starting MDV-3100. You will need to wait 30 days after stopping Zytiga [...]

  • Some Great News for our Fellow European Survivors

    Updated: 2012-06-28 20:02:17
    Recently, it was announced that there was a submission by Astellas and Medivation to the European Regulatory Agency for Enzalutamide (MDV-3100) for the treatment of men with advanced prostate cancer post-chemotherapy The basis of the submission was the pivotal phase 3 AFFIRM study. The Marketing Authorization Application (MAA) that was made to the European Medicines [...]

  • Some children with Hodgkin's lymphoma 'could be spared radiotherapy'

    Updated: 2012-06-28 12:06:00
    Some children with early-stage Hodgkin's lymphoma who respond to initial chemotherapy may not need subsequent radiotherapy, according to US research.

  • Trial launched into testosterone replacement for male cancer survivors

    Updated: 2012-06-28 00:01:00
    Cancer Research UK is today launching a trial to see if male cancer survivors could benefit from hormone replacement therapy (HRT) with testosterone.

  • Cancer campaigners bring plain packaging protest to Westminster

    Updated: 2012-06-28 00:01:00
    A GROUP of cancer campaigners covered their faces in plain packaging outside the Houses of Parliament today in support of Cancer Research UK’s latest campaign, ‘The answer is plain’. The campaign is calling on the Government to pass legislation that will require all tobacco products to be sold in plain, standardised packaging - giving health warnings more impact and putting an end to the tobacco industry’s packet racket.

  • FDA Approves the PHI Test to Screen for Prostate Cancer

    Updated: 2012-06-27 20:22:51
    Not in the normal realm of advanced prostate cancer, but important for the prostate cancer world is the news that the FDA has approved a new screening test for prostate cancer. The currently used screening tool, the PSA has only a 55% accuracy rate and as recently run into serious trouble with The U.S. Preventive [...]

  • Toxic Mediterranean "death carrot" could help treat cancer

    Updated: 2012-06-27 18:07:00
    A toxic chemical found in a Mediterranean plant is being developed into a potential new drug by an international team of researchers.

  • FDA OKs New Prostate Cancer Blood Test

    Updated: 2012-06-26 05:27:21
    A blood test for prostate cancer billed by its manufacturer as "an answer to the current PSA testing controversy" has won FDA approval, the company said.

  • Provenge and the Concern about a Rising PSA

    Updated: 2012-06-25 16:05:24
    There has been an on-going debate on the advanced prostate cancer on-line support group about the issue of the efficacy of Provenge in light of the expectation of a person’s increasing PSA number while getting the treatment. For many men with advanced prostate cancer this is a reason they elect to pass on this treatment [...]

  • Cancer threat fails to help overweight brits lose the flab

    Updated: 2012-06-25 00:01:00
    Nearly two-thirds of overweight Britons say they are struggling to find the drive to lose weight despite the vast majority knowing it increases their risk of cancer – according to a new Cancer Research UK report* published today.

  • July, the Perfect Medical Storm

    Updated: 2012-06-22 14:20:38
    If you are contemplating any sort of medical procedure during the month of July, preceed with cauction. July is the perfect storm, a time in which many unnecessary medical mistakes are to be made, especia in hospitals. July is a time when part-timers, temporary workers and newbies, none of whom know how to work with [...]

  • $40 for your thoughts about Advanced Prostate Cancer

    Updated: 2012-06-21 18:40:28
    Here’s a great opportunity to participate in an advanced prostate cancer marketing survey, earn $40 dollars for yourself and help move our understanding of our disease just a little bit further forward. What is the purpose? Understanding patients’ knowledge and perceptions of treatments for prostate cancer, so researchers can understand how prostate cancer affects patients [...]

  • Combining MDV-3100 & Provenge – A Wave of the Future?

    Updated: 2012-06-20 02:59:36
    I have heard some occasional discussion that once (that is if) enzalutamide (MDV-3100) is approved by the FDA for the treatment of men with advanced prostate cancer, it will over shadow Provenge. On the contrary, I believe that the approval of enzalutamide will actually encourage additional use of Provenge resulting in the increasing use of [...]

  • Asbestos and shift work boost work-related cancer deaths to over 8,000 a year

    Updated: 2012-06-20 00:01:00
    Around 8,000 cancer deaths in Britain each year are linked to occupations - especially those where asbestos, diesel engine fumes or shift work is involved - a new study shows today. This equates to around 5 per cent of all cancer deaths in Britain.

  • Emotional & Mental Quality of Life Improved with Early Intervention of Palliative Interventions

    Updated: 2012-06-18 17:03:43
    Advanced registered nurse practitioners (ARNP) had been integrated into the oncology team at the Mayo Clinic in Jacksonville, Florida with the purpose of discussing palliative care intervention for persons newly diagnosed with metastatic cancer. The team found that this type of intervention improved emotional and mental quality of life (QoL) for those patients who participated [...]

  • Multidisciplinary teams improve survival rates

    Updated: 2012-06-18 15:55:00
    Survival rates for women who have undergone surgery for breast cancer are improved if decisions are made as part of a healthcare team rather an individual doctor, according to a new study.

  • Zytiga to be Considered for Use in Men with Advanced Prostate Cancer Prior to Chemotherapy

    Updated: 2012-06-17 02:57:22
    Yesterday, Johnson & Johnson announced that it has asked U.S. and European Union regulators to grant broader marketing approval for its cancer pill, Zytiga which is used to treat men with castrate resistant prostate cancer. Zytiga was approved in 2011 for the treatment of advanced prostate cancer in men who have received chemotherapy and who [...]

  • Aging, Better Therapies Boost Cancer Survivor Numbers

    Updated: 2012-06-15 21:17:34
    At the start of this year, there were an estimated 13.7 million survivors of cancer living in the U.S., researchers reported, and by Jan. 1, 2022, that number is expected to rise by 31% to some 18 million.

  • NICE recommends against skin cancer drug

    Updated: 2012-06-15 11:29:00
    NICE has issued draft guidance saying the NHS should not offer the drug vemurafenib as a treatment for melanoma due to its expense.

  • Screening helps early diagnosis of bowel cancer

    Updated: 2012-06-15 08:54:00
    Patients who attend bowel screening are more likely to be diagnosed with bowel cancer at an early stage - when there is a better chance of survival - than those who wait until they have symptoms of the disease.

  • Cancer-fighting virus 'piggybacks' on blood cells

    Updated: 2012-06-13 19:00:00
    A promising type of cancer treatment called viral therapy avoids detection by the body's immune system and reaches tumours by 'piggybacking' on blood cells.

  • Studies unpick why bowel cancers become resistant to treatment

    Updated: 2012-06-13 17:53:00
    Bowel cancer cells develop resistance to new targeted cancer treatments by developing changes in a gene called KRAS, according to new research.

  • ADA: No Cancer Risk with Lantus

    Updated: 2012-06-12 20:04:37
    PHILADELPHIA -- Three observational studies showed no increased risk of cancer with use of insulin glargine (Lantus) compared with other insulins in the short term, researchers reported here.

  • Dental Plaque Linked to Cancer Risk

    Updated: 2012-06-12 16:45:21
    Regular flossing and periodic visits to the dental hygienist may be life-saving strategies, according to a team of Swedish researchers who report a link between dental plaque and cancer risk.

  • Cancer Research Technology and BioInvent enter oncology collaboration

    Updated: 2012-06-12 11:00:00
    Cancer Research Technology Ltd (CRT), the commercial arm of Cancer Research UK, and BioInvent International AB (OMXS: BINV) announced today that they have entered a collaboration with Queen Mary, University of London, to identify new therapeutic antibodies in oncology.

  • Researchers identify cervical cells most susceptible to HPV infection

    Updated: 2012-06-11 19:00:00
    Only certain types of cells in a woman's cervix are vulnerable to infection by human papillomavirus (HPV) and lead to cancer, new research suggests.

  • Cancer Research UK launches trial of experimental drug combination for advanced stomach and oesophageal cancer

    Updated: 2012-06-08 00:01:00
    Cancer Research UK’s Drug Development Office (DDO) has joined forces with academia and industry to open a clinical trial that will test an experimental drug from AstraZeneca called AZD4547 in combination with standard chemotherapy to treat a group of patients with advanced stomach or oesophageal cancer.

  • Repeated childhood CT scans increase risk of cancer in adulthood

    Updated: 2012-06-07 01:42:00
    Repeated CT scans during childhood can increase the risk of developing brain tumours or leukaemia in later life, research from the UK, US and Canada suggests.

  • New drug is 'greatest advance' for basal cell skin cancer

    Updated: 2012-06-06 19:12:00
    A new drug is effective against advanced forms of the most common type of skin cancer, according to US research.

  • Blood test provides 'snapshot' of tumour drug response

    Updated: 2012-06-04 00:00:00
    Counting the number of cancer cells in blood samples taken before and after treatment for advanced neuroendocrine tumours could provide a 'snapshot' of how well patients are responding within weeks of starting treatment, according to results from a study being presented at the American Society for Clinical Oncology cancer conference today (Monday).

  • ASCO: Untreated Prostate Cancer Responds to Zytiga

    Updated: 2012-06-03 05:20:00
    CHICAGO -- Men with metastatic castration-resistant prostate cancer had significant improvement in radiographic progression-free survival when treated with abiraterone (Zytiga) before chemotherapy, according to randomized trial results.

  • ASCO: Break from Prostate Tx Lowers Survival Odds

    Updated: 2012-06-03 05:01:00
    CHICAGO -- Interrupting androgen blockade in men with hormone-sensitive metastatic prostate cancer could shorten their lives, a researcher said here.

  • ASCO: Survival Benefit Seen with New Androgen Blocker

    Updated: 2012-06-02 22:22:43
    CHICAGO -- Men with castration-resistant prostate cancer lived almost 5 months longer when treated with enzalutamide, results of a randomized trial showed.

Current Feed Items | Previous Months Items

May 2012 | Apr 2012 | Mar 2012 | Feb 2012 | Jan 2012 | Dec 2011